Live attenuated Leishmania vaccines: a potential strategic alternative | springermedizin.at

Springer Medizin Österreich

nach oben

Archivum Immunologiae et Therapiae Experimentalis

Erschienen in:

01.04.2008 | Mini-Review

Live attenuated Leishmania vaccines: a potential strategic alternative

verfasst von: Ricardo Silvestre, Anabela Cordeiro-da-Silva, Ali Ouaissi

Erschienen in: Archivum Immunologiae et Therapiae Experimentalis | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Role of response gene to complement 32 in diseases

Nächster Artikel 1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages

Titel: Live attenuated Leishmania vaccines: a potential strategic alternative
verfasst von: Ricardo Silvestre
Anabela Cordeiro-da-Silva
Ali Ouaissi
Publikationsdatum: 01.04.2008
Verlag: Birkhäuser-Verlag
Erschienen in: Archivum Immunologiae et Therapiae Experimentalis / Ausgabe 2/2008
Print ISSN: 0004-069X
Elektronische ISSN: 1661-4917
DOI: https://doi.org/10.1007/s00005-008-0010-9

Weitere Artikel der Ausgabe 2/2008

Quantification of the CD8+ T cell response against a mucin epitope in patients with breast cancer

Open Access
Original Article

Application of two different kinds of sera against the Proteus penneri lipopolysaccharide core region in search of epitopes determining cross-reactions with antibodies

Open Access
Original Article

Current advances in the management of urticaria

Review

1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages

Open Access
Original Article

The role of B lymphocytes as antigen-presenting cells

Review

Role of response gene to complement 32 in diseases

Review